Alligator Bioscience Sets TO 14 Warrant Exercise Price at SEK 0.20

Alligator Bioscience AB ( (SE:ATORX) ) has shared an update.

Alligator Bioscience has set the exercise price for its TO 14 warrants at SEK 0.20 per share, following a rights issue and directed issue that together created 245,351,657 outstanding warrants. The exercise period runs from 5 to 19 March 2026, with trading in the warrants on Nasdaq Stockholm ending on 17 March 2026.

If all TO 14 warrants are exercised, the company stands to raise approximately SEK 49 million before issue costs and will issue up to 245,351,657 new shares, increasing total shares to 779,868,643. Such full exercise would result in about 31 percent dilution for existing shareholders, but would significantly strengthen Alligator Bioscience’s capital base to support its operations and development pipeline.

The most recent analyst rating on (SE:ATORX) stock is a Sell with a SEK0.16 price target. To see the full list of analyst forecasts on Alligator Bioscience AB stock, see the SE:ATORX Stock Forecast page.

More about Alligator Bioscience AB

Alligator Bioscience AB is a Swedish biotechnology company based in Lund, focused on developing antibody-based immuno-oncology therapies. The company targets cancer treatment through advanced biological drug candidates, positioning itself within the competitive global cancer immunotherapy market.

Average Trading Volume: 4,901,351

Technical Sentiment Signal: Strong Sell

Current Market Cap: SEK99.15M

See more data about ATORX stock on TipRanks’ Stock Analysis page.